Detalles de la búsqueda
1.
Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trial.
Breast Cancer Res Treat
; 150(2): 279-88, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25721604
Resultados
1 -
1
de 1
1
Próxima >
>>